Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

22.92 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 42,907
Open 22.92
Bid (Size) 23.00 (4)
Ask (Size) 23.02 (47)
Prev. Close 22.92
Today's Range 22.92 - 22.92
52wk Range 20.91 - 31.54
Shares Outstanding 5,606,688,356
Dividend Yield 7.50%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pfizer Stock Climbs Pre-Market On Bladder Cancer Trial Success: Retail Digests Data Ahead Of Q1 Print
Pfizer highlighted positive late-stage results for its experimental bladder cancer drug, sasanlimab, as it looks to strengthen its oncology portfolio and offset losses from recent setbacks in its... 
Via Stocktwits
Topics Intellectual Property
Exposures Intellectual Property
Generic Pharmaceuticals Stocks Q4 Teardown: Viatris (NASDAQ:VTRS) Vs The Rest
Let’s dig into the relative performance of Viatris (NASDAQ:VTRS) and its peers as we unravel the now-completed Q4 generic pharmaceuticals earnings season. 
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property

Performance

YTD
-13.9%
-13.9%
1 Month
-9.1%
-9.1%
3 Month
-14.7%
-14.7%
6 Month
-20.6%
-20.6%
1 Year
-10.6%
-10.6%

More News

Read More
My 5 Top Stocks to Buy Right Now in This Highly Volatile Market
Via The Motley Fool
Topics Artificial Intelligence Energy
Exposures Artificial Intelligence Fossil Fuels
Pfizer (PFE) Reports Q1: Everything You Need To Know Ahead Of Earnings
Via StockStory
Topics Government World Trade
Exposures Political Tariff
The Week Ahead: PCE Inflation Data And Big Tech Earnings In Focus
Via Talk Markets
Topics Economy Government Stocks / Equities
Exposures Interest Rates Political
1 Superstar Dividend Growth Stock to Buy if the Market Crashes
Via The Motley Fool
Topics Economy Government
Exposures Interest Rates Political
Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer
From Pfizer Inc.
Via Business Wire
SpringWorks Therapeutics Retail Chatter Spikes As Germany’s Merck Confirms Late-Stage Talks For $3.5B Buyout
Via Stocktwits
Most active S&P500 stocks in Thursday's session
Via Chartmill
Guardant Health, Pfizer Collaborate To Develop New Cancer Therapies Using Liquid Biopsy Platform
Via Benzinga
5 All-Weather Dividend Stocks to Buy Right Now
Via The Motley Fool
Topics Economy
Exposures Interest Rates
2 No-Brainer Stocks to Buy With Less Than $30
Via The Motley Fool
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
3 Reasons VTRS is Risky and 1 Stock to Buy Instead
Via StockStory
Should You Buy the 3 Highest-Paying Dividend Stocks in the S&P 500?
Via The Motley Fool
Topics Government Stocks World Trade
Exposures Political Tariff US Equities
Summit Therapeutics Retail Traders Stoked As Stock Surges On Promising Cancer Drug Trial
Via Stocktwits
Novavax's COVID-19 Vaccine Nears FDA Full Approval, Stock Jumps
Via Benzinga
Exposures COVID-19 Product Safety
Pfizer Declares Second-Quarter 2025 Dividend
From Pfizer Inc.
Via Business Wire
Looking for the most active stocks in the S&P500 index on Wednesday?
Via Chartmill
Why Is Summit Therapeutics Stock Soaring On Wednesday?
Via Benzinga
Pfizer Advances Bold Vision for Future of Cancer Care at the ASCO 2025 Annual Meeting
From Pfizer Inc.
Via Business Wire
Novavax Signals Chances Of FDA Approval For Its COVID-19 Vaccine: But Retail Sentiment Wavers
Via Stocktwits
Topics Government
Exposures COVID-19 Political Product Safety
3 of Wall Street’s Favorite Stocks Walking a Fine Line
Via StockStory
2 High-Yield Dividend Stocks to Buy for Passive Income
Via The Motley Fool
Topics Retirement
Exposures COVID-19 Pension
Trump Administration Considers Lowering US Drug Prices To International Levels: Report
Via Benzinga
Topics Government
Exposures Political
Eli Lilly Nails Oral GLP-1 Trial—Here’s What It Means for LLY
Via MarketBeat

Frequently Asked Questions

Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 22.92
When was Pfizer last traded?
The last trade of Pfizer was at 04/25/25 07:00 PM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 128.51B
How many shares of Pfizer are outstanding?
Pfizer has 129B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.